Coya Therapeutics
COYA | NASDAQ
$3.00
-$0.13 (-4.15%)
At close: Nov 16, 2026, 4:00 PM ET
$2.96
-$0.04 (-1.33%)
After-hours:
Nov 16, 2026, 7:30 PM ET
-4.15%
(1D)No price chart data available for 1D timeframe.
Rating
31.8
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #748/1021 (Top 73%)
Key Statistics
Market Data
Market Cap $70.37M
1D Range
2.96 3.18
52W Range
2.81 6.51
Valuation (TTM)
PE -2.16
PB 2.10
EV/EBITDA -1.13
Valuation (NTM)
Forward PE N/A
Forward PEG -0.09
Price Target $12.00
Cash Flow
FCF Yield -29.8%
SBC Adj. FCF Yield -37.1%
SBC Impact -24.6%
Margins
Gross Margin 100.0%
Operating Margin -675.3%
FCF Margin -446.6%
Growth (CAGR)
Revenue 3Y | 5Y -40.0% |
36.7%
Dil EPS 3Y | 5Y -33.5% |
2.9%
FCF 3Y | 5Y -37.6% |
-25.5%
Returns
ROA -76.7%
ROE -71.5%
ROIC -93.3%
Financial Health
Net Cash
$35.8M
Current Ratio 7.24
Interest Coverage 0.00
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Coya Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing innovative therapeutic agents that fine-tune the function of regulatory T cells (Tregs). Its therapeutic pipelin...
Sector Healthcare
Industry Biotechnology
Employees 8
IPO Date Dec 29, 2022
Website www.coyatherapeutics.com
Fiscal Year January - December
Latest News
No news articles available yet.
Earnings
Latest Earnings
Nov 10, 2026
EPS
-$0.45
Miss -32.35%
YoY:
-350.00% REV
$234.13K
Beat +112.85%
YoY:
-93.43%Next Earnings
Mar 15, 2027
EPS Est
Pro
Rev Est
Pro
Analyst Summary
# of Analysts
5
Consensus
Buy
Price Target
$12.00
Upside
+300.00%
Buy (5)
Hold (0)
Sell (0)
Add to Watchlist
Select watchlists to add or remove COYA